Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 10/2010

Inhalt (17 Artikel)

Original Paper

Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line

Ramin Ataee, Soheila Ajdary, Mohammadreza Zarrindast, Mehdi Rezayat, Mohammad Reza Hayatbakhsh

Original Paper

The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer

Ramazan Yildiz, Mustafa Benekli, Suleyman Buyukberber, Ali Osman Kaya, Banu Ozturk, Emel Yaman, Veli Berk, Ugur Coskun, Deniz Yamac, Banu Sancak, Aytug Uner

Original Paper

Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis

Guopei Zheng, Fang Peng, Renkui Ding, Yanhui Yu, Yongmei Ouyang, Zhuchu Chen, Zhiqiang Xiao, Zhimin He

Original Paper

Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma

Zhou Yuan, Qi Zheng, Jia Fan, Kai-xing Ai, Jie Chen, Xin-yu Huang

Original Paper

The influence of TXNDC5 gene on gastric cancer cell

Lin Zhang, Yanhong Hou, Nan Li, Kai Wu, Junshan Zhai

Original Paper

Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study

Dechao Jiao, Linxue Qian, Yanling Zhang, Fujun Zhang, Chuanxing Li, Zilin Huang, Liang Zhang, Weidong Zhang, Peihong Wu, Xinwei Han, Guangfeng Duan, Jianjun Han

Original Paper

Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case–control study in an Indian population

Jingwen Wang, Yang Zhao, Jing Jiang, Vendhan Gajalakshmi, Kiyonori Kuriki, Seiichi Nakamura, Susumu Akasaka, Hideki Ishikawa, Sadao Suzuki, Teruo Nagaya, Shinkan Tokudome

Original Paper

Overexpression of Galectin-1 is negatively correlated with pathologic differentiation grade in oral squamous cell carcinoma

Lai-ping Zhong, Kui-jie Wei, Xiao Yang, Hong-ya Pan, Dong-xia Ye, Li-zhen Wang, Zhi-yuan Zhang

Original Paper

Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells

Kawin Leelawat, Wandee Udomchaiprasertkul, Siriluck Narong, Surang Leelawat

Original Paper

Perineural invasion in carcinoma of the cervix uteri—prognostic impact

Lars-Christian Horn, Alexandra Meinel, Uta Fischer, Karl Bilek, Bettina Hentschel

Original Paper

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance

Georgia Levidou, Angelica A. Saetta, Maria Karlou, Irene Thymara, Harris Pratsinis, Petros Pavlopoulos, Dimitrios Isaiadis, Kalliopi Diamantopoulou, Efstratios Patsouris, Penelope Korkolopoulou

Original Paper

Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma

Xiaohan Li, Takeshi Nishida, Akira Noguchi, Yang Zheng, Hiroyuki Takahashi, Xianghong Yang, Shinji Masuda, Yasuo Takano

Original Paper

Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer

Zhengbin Shen, Shuang Zhou, Yanna Wang, Ri-lun Li, Cuiping Zhong, Chunmin Liang, Yihong Sun

Original Paper

Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways

Tongsen Zheng, Jiabei Wang, Xuan Song, Xianzhi Meng, Shangha Pan, Hongchi Jiang, Lianxin Liu

Original Paper

Biphasic effect of a primary tumor on the growth of secondary tumor implants

Juan Bruzzo, Paula Chiarella, Roberto P. Meiss, Raúl A. Ruggiero

Original Paper

Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma

Mingzhen Ying, Dawei Li, Linjun Yang, Mei Wang, Ning Wang, Ying Chen, Miaoxia He, Yajie Wang

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.